Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac

Pharmazie

Volumn 66, Issue 4, 2011, Pages 249-257

  Nagda, C D ^a   Chotai, N P ^b   Nagda, D C ^b   Patel, S B ^a   Patel, U L ^c  

^a Indukaka Ipcowala College of Pharmacy   (India)

^b AR Patel and GH Patel Institute of Pharmacy   (India)

^c Arihant School of Pharmacy   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; CHITOSAN; KETOROLAC; MICROSPHERE; MUCOADHESIVE MICROSPHERE; NANOCARRIER; NANOPARTICLE; POLYCARBOPHIL; SOLVENT; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; EVAPORATION; IN VITRO STUDY; KINETICS; NANOENCAPSULATION; NASAL CILIOTOXICITY; NOSE MUCOSA; SCANNING ELECTRON MICROSCOPE; TOXICITY;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CILIA; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EMULSIONS; KETOROLAC; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; NASAL MUCOSA; PARTICLE SIZE; SHEEP; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE ADHESIVES;

EID: 79957645324     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0277     Document Type: Article

References (46)

1. Abd El-Hameed M, Kellaway I (1997) Preparation and in vitro characterization of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur J Pharm Biopharm 44: 53-60.
2. Agarwal V, Mishra B (1999) Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm 25: 701-709. (Pubitemid 29239399)
3. Amrish C, Sharma PK (2009) Transdermal delivery of ketorolac. Yakugaku Zasshi 129: 373-379.
4. Arora R, Srivastava AK, Rani M, Mishra B (2002) Investigation on osmotic matrix tablets as controlled delivery systems of ketorolac tromethamine. Acta Pharm Turcica 44: 87-96. (Pubitemid 36287789)
5. Basu SK, Kavitha K, Rupeshkumar M (2010) Evaluation of ketorolac tromethamine microspheres by chitosan/gelatin b complex coacervation. Sci Pharm 78: 79-92.
6. Brime B, Ballesteros MP, Frutos P (2000) Preparation and in vitro characterization of gelatin microspheres containing levodopa for nasal administration. J Microencap 17: 777-784.
7. Brocks DR, Jamali F (1992) Pharmacokinetics of ketorolac tromethamine. Clin Pharmacokin 23: 415-427.
8. Buckely M, Brogden R (1990) Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 39: 86-109.
9. Burjak M, Bogataj M, Velnar M, Grabnar I, Mrhar A (2001) The study of drug release from microspheres adhered on pig vesical mucosa. Int J Pharm 224: 123-130. (Pubitemid 32706491)
10. Chelladurai S, Mishra M, Mishra B (2008) Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine. Chem Pharm Bull 56: 1596-1599.
11. Costa P, Lobo J (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13: 123-133. (Pubitemid 32288781)
12. Dinarvand R, Mahmoodi S, Farboud E (2004) Effect of process variables on particle size of gelatin microspheres containing lactic acid. Pharm Dev Tech 9: 291-299. (Pubitemid 39166281)
13. Dubey RR, Parikh RH (2004) Two-stage optimization process for formulation of chitosan microspheres. AAPS PharmSciTech 5: 1-9.
14. Filipovic J, Becirevic M, Skalko N, Jalsenjak I (1996) Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. Int J Pharm 135: 183-190. (Pubitemid 26260888)
15. Hafner A, Filipovic-Grcic J (2007) Development and in vitro characterization of chitosan-based microspheres for nasal delivery of promethazine. Drug Dev Ind Pharm 33: 427-436.
16. Harris SA, Ohin M, Svensson S, Lethagen D, Nilsson IM (1989) Effect of viscosity on the pharmacokinetics and biological response to intranasal destiiopressin. J Pharm Sci 78: 470-471.
17. Hascicek C, Gonul N, Erk N (2003) Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization. Farmaco 58: 11-16. (Pubitemid 38365966)
18. He P, Davis SS, Illum L (1998) In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 166: 75-88.
19. Jadhav KR, Gambhire MN, Shaikh IM, Kadam VJ, Pisal SS (2007) Nasal drug delivery system-factors affecting and applications. Current Drug Therapy 2: 27-38. (Pubitemid 46723136)
20. Jain SK, Chourasia MK, Jain AK, Jain RK (2004) Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv 11: 113-122. (Pubitemid 38437080)
21. Karatas A, Baykara T (2006) Studies on release of ketorolac tromethamin and indomethacin from ophthalmic hydrogel inserts. J Fac Pharm Ankara 35: 255-268. (Pubitemid 350228852)
22. Kumar M, Pathak K, Misra A (2009) Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm 35: 387-395.
23. Mahajan HS, Gattani SG (2009) Nasal administration of ondansetron using a novel microspheres delivery system. Pharm Dev Technol 14: 226-232.
24. Maiti S, Dey P, Kaity S, Ray S, Maji S, Sa B (2009) Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS PharmSciTech 10: 703-715.
25. Martinac A, Filipovic-Grcic J, Perissutti B, Voinovich D, Pavelic Z (2005) Spray-dried chitosan/ethylcellulose microspheres for nasal drug delivery: Swelling study and evaluation of in vitro drug release properties. J Microencapsul 22: 549-561. (Pubitemid 43123893)
26. Mathew ST, Devi SG, Sandhya KV (2007) Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration. AAPS PharmSciTech 8: E1-E9.
27. Mroszczak J, Lee FW, Combs D, Sarnquist FH, Huang BL, Wu AT, et al. (1987) Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 15: 618-626. (Pubitemid 18004616)
28. Nagai T, Nishimoto Y, Nanibu N, Suzuki Y, Sekine K (1984) Powder dosage form of insulin for nasal administration. J Control Release 1: 15-22. (Pubitemid 15175635)
29. Nagda C, Chotai N P, Patel U, Patel S, l SoniT, Patel P, Hingorani L (2009) Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac. Drug Dev Ind Pharm 35: 1155-1166.
30. Pereswetoff-Morath L (1998) Microspheres as nasal drug delivery systems. Adv Drug Del Rev 29: 185-194.
31. Puri V, Bansal AK (2004) In vitro-in vivo characterization of release modifying agents for parenteral sustained-release ketorolac formulation. Drug Dev Ind Pharm 30: 619-624.
32. Quadir M, Zia H, Needham TE (2000) Development and evaluation of nasal formulations of ketorolac. Drug Deliv 7: 223-229. (Pubitemid 32057554)
33. Rathananand M, Kumar DS, Shirwaikar A, Kumar R, Sampath Kumar D, Prasad RS (2007) Preparation of mucoadhesive microspheres for nasal delivery by spray drying. Ind J Pharm Sci 69: 651-657.
34. Reddy PB, Dorle AK, Krishna DR (1990) Albumin microsphere: effect of process variables on size distribution and in-vitro release. Drug Dev. Ind. Pharm 16: 1791-1803. (Pubitemid 20230583)
35. Rokhade AP, Agnihotri SA, Patil SA, Mallikarjuna NN, Kulkarni PV, Aminabhavi TM (2006) Semi-interpenetrating polymer network microspheres of gelatin and sodium carboxymethyl cellulose for controlled release of ketorolac tromethamine. Carbohyd Polym 65: 243-252. (Pubitemid 44142095)
36. Rouzi B, Tosi G, Forni F, Vandelli MA (2005) Ketorolac tromethamine liposomes: Encapsulation and release studies. J Liposome Res 15: 175-185. (Pubitemid 43062266)
37. Sankar C, Mishra B (2003) Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm 53: 101-110.
38. Shanmuganathan S, Shanumugasundaram N, Adhirajan N, Ramyaa Lakshmi TS, Babu M (2008) Preparation and characterization of chitosan microspheres for doxycycline delivery. Carbohyd Polym 73: 201-211.
39. Sinha VR, Trehan A (2005) Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres. Drug Deliv 12: 133-139. (Pubitemid 40604992)
40. Tas C, Ozkan CK, Savaser A, Ozkan Y, Tasdemir U, Altunay H (2006) Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation. Eur J Pharm Biopharm 64: 246-254. (Pubitemid 44308522)
41. Ugwoke MI, Agu RU, Verbeke N, Kinget R (2005) Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Deliv Rev 57: 1640-1665. (Pubitemid 41443473)
42. Ugwoke MI, Verbeke N, Kinget R (2001) The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53: 3-22.
43. Varma M, Singla AK, Dhawan S (2004) Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev Ind Pharm 30: 543-553.
44. Vatsaraj N, Zia H, Needham T (2002) Formulation and optimization of a sustained-release tablet of ketorolac tromethamine. Drug Deliv 9: 153-159.
45. Vivek K, Reddy H, Murthy RSR (2007) Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres. Pharm Dev Tech 12: 79-88. (Pubitemid 46902616)
46. Wagner W, Khanna P, Furst DE (2007) Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics and drugs used in gout. In: Katzung BG (ed.) Basic and Clinical Pharmacology, 10th ed., New York, p. 586.